NICOTINE TRANSDERMAL SYSTEM STEP 1- nicotine patch, extended release 
NICOTINE TRANSDERMAL SYSTEM STEP 2- nicotine patch, extended release 
Chain Drug Marketing Association Inc.

----------

Nicotine Transdermal System, Step 1 and Step 2

 Drug Facts

Active ingredient (in each patch)

Active ingredient Step 1
Nicotine, 21mg delivered over 24 hours

Active ingredient Step 2
Nicotine, 14 mg delivered over 24 hours

Purpose

Stop smoking aid

Use

reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

Warnings

If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider. Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.

Do not use

Ask a doctor before use if you have

Ask a doctor or a pharmacist before use if you are

When using this product

Stop use and ask a doctor if

Keep out of reach of children and pets.

Used patches have enough nicotine to poison children and pets. If swallowed, get medical help or contact a Poison Control Center right away. Save pouch to use for patch disposal. Dispose of used patch by folding sticky ends together and putting in pouch.

Directions

qc-schedule image
 

Other information

store at 20°-25°C (68°-77°F)

Inactive ingredients

acrylate adhesive, polyester, silicone adhesive

Comments or questions?

Call 1-877-440-7867

Principal Display Panel

NDC 63868-190-14

*Compare to the active ingredient in HABITROL®

Clear
Nicotine
Transdermal System
Step 1

Stop Smoking Aid
Nicotine/21 mg Delivered Over 24 Hours
Includes:

Behavior Support Program with Self-Help Guide
Free Audio CD Upon Request. See self-help guide inside.

If you Smoke MORE than 10 cigarrettes per day:
Start with Step 1
If you smoke 10 or LESS cigarrettes per day:
Start with Step 2

21 mg
14 Pactches

©Distributed by
C.D.M.A, Inc.
Novi, MI 48376-0995
www.qualitychoice.com
Questions: 248-449-9300

qc-nicotine step 1 carton

Principal Display Panel

NDC 63868-190-14

*Compare to the active ingredient in HABITROL®

Clear
Nicotine
Transdermal System
Step 2

Stop Smoking Aid
Nicotine/21 mg Delivered Over 24 Hours
Includes
:
Behavior Support Program with Self-Help Guide
Free Audio CD Upon Request. See self-help guide inside.

If you Smoke MORE than 10 cigarrettes per day:
Start with Step 1
If you smoke 10 or LESS cigarrettes per day:
Start with Step 2

14 mg
14 Pactches

©Distributed by
C.D.M.A, Inc.
Novi, MI 48376-0995
www.qualitychoice.com
Questions: 248-449-9300

qc-nicotine-step 2
NICOTINE TRANSDERMAL SYSTEM  STEP 1
nicotine patch, extended release
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63868-190
Route of AdministrationTRANSDERMAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NICOTINE (UNII: 6M3C89ZY6R) (NICOTINE - UNII:6M3C89ZY6R) NICOTINE21 mg  in 24 h
Inactive Ingredients
Ingredient NameStrength
HEPTANE (UNII: 456148SDMJ)  
XYLENE (UNII: D856J1047R)  
ETHYL ACETATE (UNII: 76845O8NMZ)  
ISOPROPYL ALCOHOL (UNII: ND2M416302)  
TOLUENE (UNII: 3FPU23BG52)  
ETHYLBENZENE (UNII: L5I45M5G0O)  
VINYL ACETATE (UNII: L9MK238N77)  
HIGH DENSITY POLYETHYLENE (UNII: UG00KM4WR7)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63868-190-1414 in 1 CARTON
11 in 1 POUCH
124 h in 1 PATCH
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07461210/01/1999
NICOTINE TRANSDERMAL SYSTEM  STEP 2
nicotine patch, extended release
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63868-191
Route of AdministrationTRANSDERMAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NICOTINE (UNII: 6M3C89ZY6R) (NICOTINE - UNII:6M3C89ZY6R) NICOTINE14 mg  in 24 h
Inactive Ingredients
Ingredient NameStrength
HEPTANE (UNII: 456148SDMJ)  
XYLENE (UNII: D856J1047R)  
ETHYL ACETATE (UNII: 76845O8NMZ)  
ISOPROPYL ALCOHOL (UNII: ND2M416302)  
TOLUENE (UNII: 3FPU23BG52)  
ETHYLBENZENE (UNII: L5I45M5G0O)  
VINYL ACETATE (UNII: L9MK238N77)  
HIGH DENSITY POLYETHYLENE (UNII: UG00KM4WR7)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63868-191-1414 in 1 CARTON
11 in 1 POUCH
124 h in 1 PATCH
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07461210/01/1999
Labeler - Chain Drug Marketing Association Inc. (011920774)

Revised: 6/2014
Document Id: e38c24f2-0867-44f4-bb5e-b896af84ba7d
Set id: f363ca90-6c4a-4d45-9b1d-3a6fb1cddecd
Version: 1
Effective Time: 20140619
 
Chain Drug Marketing Association Inc.